Enterococcus casseliflavus septicaemia associated with hepatobiliary infection in a 75-year-old man.

Related Articles

Enterococcus casseliflavus septicaemia associated with hepatobiliary infection in a 75-year-old man.

BMJ Case Rep. 2017 May 12;2017:

Authors: Verma R, Baroco AL

Abstract
Enterococcus casseliflavus is a rare non-faecium, non-faecalis, vancomycin-resistant enterococcus (VRE) that is responsible for up to 2% of all enterococcal infections. Septicaemia with this bacterium is usually seen in older patients with multiple comorbidities who have had several previous hospitalisations. Septicaemia with E. casseliflavus portends a poorer prognosis, and treatment usually involves administration of antienterococcal beta-lactams or anti-VRE medications such as linezolid or daptomycin. We present such a case of a 75-year-old man who developed E. casseliflavus septicaemia of presumably hepatobiliary origin and responded well to treatment with intravenous beta-lactams.

PMID: 28500123 [PubMed - in process]